Definitive Healthcare to Present at the 51st Annual J.P. Morgan Global Technology,…
<!-- Name:DistributionId Value:8839677 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
J.P
J.P. Morgan: Judicial reform could hit Israel’s credit rating
J.P. Morgan's research department has published a survey on the Israeli economy entitled "Israel Strategy: Domestic volatility flares up."
In the report the US…
Cerevel Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference and…
Initiated Phase 1 healthy volunteer trial to support development of emraclidine in Alzheimer’s disease psychosis in Q4 2022; second potential indication as a once-daily treatment Phase 2…
Axiom Real-Time Metrics Attending J.P. Morgan Healthcare and Biotech Showcase…
TORONTO, Jan. 08, 2023 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services focused on small-to-medium life science…
Ascendis Pharma Provides Update on Vision 3×3 Strategic Roadmap at 41st Annual…
– On track to fulfill all elements of Vision 3x3 to build a sustainable, profitable, leading biopharma company COPENHAGEN, Denmark, Jan. 08, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma…
Lantheus to Present at the J.P. Morgan 2023 Healthcare Conference
NORTH BILLERICA, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics,…
HilleVax to Present at the 41st Annual J.P. Morgan Healthcare Conference
BOSTON, Jan. 04, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today…
Umoja Biopharma to Present at the 41st Annual J.P. Morgan Healthcare Conference
SEATTLE, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells to treat…
Allogene Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic…
Dyadic to Attend J.P. Morgan 41st Annual Healthcare Conference
JUPITER, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative…